Direct-acting antivirals reduce the risk of non-hepatic cancers among hepatitis C virus-infected patients

被引：0
|
作者：
Wang, Wei [1 ]
Lo Re, Vincent, III [2 ]
Xiao, Hong [1 ]
Brown, Joshua [1 ]
Guo, Yi [1 ]
Park, Haesuk [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
848
引用
收藏
页码：387 / 388
页数：2
相关论文
共 50 条
  • [1] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199
  • [2] Impact of hepatitis C virus treatment on the risk of non-hepatic cancers among hepatitis C virus-infected patients in the US
    Wang, Wei
    Lo Re, Vincent, III
    Guo, Yi
    Xiao, Hong
    Brown, Joshua
    Park, Haesuk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1592 - 1602
  • [3] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [4] Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer
    Economides, M. P.
    Mahale, P.
    Kyvernitakis, A.
    Turturro, F.
    Kantarjian, H.
    Naing, A.
    Hosry, J.
    Shigle, T. L.
    Kaseb, A.
    Torres, H. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (11-12) : 1235 - 1241
  • [5] Efficacy and Safety of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients Taking Proton Pump Inhibitors
    Wijarnpreecha, Karn
    Chesdachai, Supavit
    Thongprayoon, Charat
    Jaruvongvanich, Veeravich
    Ungprasert, Patompong
    Cheungpasitporn, Wisit
    HEPATOLOGY, 2017, 66 : 625A - 625A
  • [6] EFFECTIVENESS AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN PSYCHIATRIC HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, Luis
    Bobadilla-Perez, Eva
    Carlos Yanez-Rubal, Juan
    Prieto-Perez, Andrea
    Cid-Silva, Purificacion
    Rodriguez-Sotelo, Alejandro
    Gimenez-Arufe, Victor
    Quiroga-Fernandez, Candela
    Isabel Sanclaudio-Luhia, Ana
    Novo-Ponte, Ana
    Mena-De-Cea, Alvaro
    Martin-Herranz, Isabel
    Castro-Iglesias, Angeles
    HEPATOLOGY, 2019, 70 : 966A - 966A
  • [7] Retreatment of Hepatitis C Virus-Infected Patients with Direct-Acting Antiviral Failures
    Pawlotsky, Jean-Michel
    SEMINARS IN LIVER DISEASE, 2019, 39 (03) : 354 - 368
  • [8] The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis
    Huang, Peng
    Wang, Yan
    Yue, Ming
    Ge, Zhijun
    Xia, Xueshan
    Jeyarajan, Andre J.
    Holmes, Jacinta A.
    Yu, Rongbin
    Zhu, Chuanwu
    Yang, Sheng
    Lin, Wenyu
    Chung, Raymond T.
    LIVER INTERNATIONAL, 2021, 41 (10) : 2341 - 2357
  • [9] Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
    Sung, Pil Soo
    Shin, Eui-Cheol
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [10] The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders
    Jiang, Xinyi
    Song, Hyun Jin
    Wang, Wei
    Henry, Linda
    Childs-Kean, Lindsey M.
    Lo Re, Vincent, III
    Park, Haesuk
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 873 - 881
12345